SMO and basal cell carcinoma: Mutation of SMO 535 Tryptophan (W) into Leucine (L) (SMOW535L) leads to constitutive activation of SMO and has been found as oncogenic driver mutations in medulloblastoma and basal cell carcinoma.5, 19, 20, 21